Biopharmaceuticals have transformed the patient care landscape, but alongside this step change in treatment capability comes the need for a similar paradigm shift in manufacturing capability. Here, Maik W Jornitz, President & CEO of G-CON Manufacturing Inc. highlights how cleanroom infrastructure must develop to keep pace with ever evolving industry needs.
List view / Grid view
G-CON Manufacturing Inc.
Welcome to European Pharmaceutical Review’s roundtable devoted to continuous manufacturing. We have brought together six industry experts to focus on how the contribution of continuous manufacturing technology is shaping the pharmaceutical sector and explain what factors are driving that change.